Wednesday, 7 August 2019

Novartis C.E.O. Defends Company’s Decision to Withhold False Data From the F.D.A.

By KATIE THOMAS from NYT Health https://ift.tt/2YPZ7...

FDA: Pricey Drug Approved on Manipulated Data

The FDA approved the gene therapy Zolgensma to treat children with a severe form of spinal muscular atrophy. The drug costs $2.125 million for a one-time treatment, CBS News reported. from WebMD Health https://ift.tt/2ZFHn...

One Dead In Atlanta Hotel Legionnaires' Outbreak

Another 61 probable cases of the disease have been identified, according to Nancy Nydam, director of communications at Georgia Department of Public Health, CNN reported. from WebMD Health https://ift.tt/2YvQs...

Tuesday, 6 August 2019

Novartis Hid Manipulated Data While Seeking Approval for $2.1 Million Treatment

By KATIE THOMAS from NYT Health https://ift.tt/2M3PJ...